Evaxion A (EVAX) Receivables - Other (2019 - 2024)

Evaxion A (EVAX) posted Receivables - Other of $65000.0 for Q4 2024, down 39.81% on a QoQ basis from $108000.0 in Q4 2023, and down 39.81% year-over-year from $108000.0 in Q1 2024.

Evaxion A (EVAX) Receivables - Other (2019 - 2024) Analysis & Trends

Evaxion A's Receivables - Other history runs 6 years deep, the most recent figure standing at $65000.0 for Q4 2024.

  • Quarterly Receivables - Other fell 39.81% year-over-year to $65000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $65000.0 (down 39.81% YoY) and the FY2024 annual result came in at $65000.0, down 39.81% from the prior year.
  • Receivables - Other was $65000.0 for Q4 2024 at Evaxion A, down from $108000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $113000.0 in Q4 2021 and bottomed at $7000.0 in Q4 2020.
  • A 5-year average of $60600.0 and a median of $65000.0 in 2024 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2021 — Receivables - Other soared 1514.29% — and 2022, when it tumbled 91.15%.
  • Evaxion A's Receivables - Other stood at $7000.0 in 2020, then surged by 1514.29% to $113000.0 in 2021, then tumbled by 91.15% to $10000.0 in 2022, then soared by 980.0% to $108000.0 in 2023, then tumbled by 39.81% to $65000.0 in 2024.
  • Business Quant data shows EVAX's Receivables - Other at $65000.0 in Q4 2024, $108000.0 in Q4 2023, and $10000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Evaxion A 25.44 Mn 25.44 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 65,000.00
Dec 31, 2024 65,000.00
Dec 31, 2023 108,000.00
Dec 31, 2023 108,000.00
Dec 31, 2022 10,000.00
Dec 31, 2022 10,000.00
Dec 31, 2021 113,000.00
Dec 31, 2021 113,000.00
Dec 31, 2020 7,000.00
Dec 31, 2020 7,000.00
Dec 31, 2019 32,000.00
Dec 31, 2019 32,000.00